We examined the importance of decreased heart rate in the beneficial effect of/3-adrenergic blockade on exercise-induced regional myocardial ischemia and contractile dysfunction in conscious dogs with single vessel coronary stenosis (ameroid constrictor). Studies were performed during control treadmill exercise, which produced regional myocardial ischemia (blood flow measured with microspheres) and wall dysfunction (measured using sonomicrometers). A second run was performed after the administration of atenolol (0.3-1.0 mg/kg i.v.), and the reduced heart rate caused by atenolol during early steady-state running was then prevented by atrial pacing during the latter portion of the run. Atenolol reduced the exercise heart rate from 217 ± 25 beats per minute (SD, n = 9) to 166 ± 15, and ischemic zone wall thickening during systole improved from 27 ± 22% of the resting value in the control run to 50 ± 25% of the resting value in the atenolol run (p<0.01). Atrial pacing then increased heart rate to 217 ± 23 beats per minute, and regional wall thickening deteriorated to 15 ± 25% of the resting value. Regional subendocardial blood flow in the ischemic zone during atrial pacing with atenolol was slightly less than that observed in the control run, in both ischemic and control zones, indicating no remaining beneficial effect of atenolol when heart rate reduction was eliminated. We conclude that the only significant mechanism for the improvement in exercise-induced ischemia and wall motion produced by atenolol is a reduction in the exercise heart rate. Furthermore, when the heart rate decrease was prevented, regional blood flow and function tended to be more depressed after atenolol than during the control run. (Circulation Research 1987;60:738-746) 
V arious pharmacologic agents are used clinically to treat effort-induced angina pectoris. Several of these commonly used drugs were tested in a dog model of single vessel critical coronary stenosis and were shown to improve regional myocardial blood flow and function in the ischemic myocardium during exercise. 1 " 1 Although the overall efficacy of these therapeutic interventions was confirmed in terms of improved regional myocardial blood flow and function, the mechanisms involved in eliciting the beneficial effect are difficult to determine in such a complex experimental animal model. Until now, discussion of the mode of action of these anti-anginal drugs has been necessarily inferential.
One such mechanism is the decrease in exercise heart rate that is observed following administration of /3-adrenergic blocking drugs 1 and certain calcium channel blockers 2 that are effective in treating effort angina pectoris. A reduced heart rate is advantageous in a setting of restricted coronary inflow since diastolic perfusion time increases, thus improving blood flow especially to the subendocardium. 3 ' 6 /3-Blockade produces a negative inotropic effect (in addition to the negative chronotropic effect), which reduces oxygen consumption of the nonischemic tissue adjacent (transmurally and laterally) to the ischemic zone. Therefore, the potential for a steal phenomenon is reduced, 78 which could improve perfusion of an ischemic region. In addition, it has been suggested that when myocardial oxygen consumption of the ischemic myocardium is reduced by /3-adrenergic blockade (slowed heart rate and reduced arterial pressure), the discrepancy between the demand for blood flow and the limited supply to the ischemic tissue is attenuated, which may result in improved regional function. 9 Finally, reduced left ventricular pressure (LVP) during exercise following /3-blockade 1 may contribute to the improvement in regional myocardial function in the ischemic myocardium. Thus, a variety of mechanisms potentially have a role in reducing exercise-induced regional myocardial ischemia and dysfunction.
The purpose of this study was to determine the importance of heart rate reduction to the overall efficacy of cardioselective y3-adrenergic blockade using atenolol in a dog model of single vessel coronary stenosis.
To accomplish this, we tested the hypothesis that atenolol would fail to improve exercise-induced ischemia and wall dysfunction when its bradycardic effect during exercise is prevented by atrial pacing.
Materials and Methods

Animal Model
The animals used in this study were handled in accordance with the animal welfare regulations of the University of California San Diego, and the experimental protocol was approved by the Animal Subjects Committee of this institution.
Data from 9 adult mongrel dogs (27.2 ± 3.3 kg, mean ± SD) are reported. Before undergoing surgery, each dog received extensive training to allow comfortable running on a motor-driven treadmill. The dogs were initially tranquilized with acepromazine maleate (0.4 mg/kg i.m.). Anesthesia was provided using sodium pentobarbital (26 mg/kg i.v.) and further analgesia was produced using morphine sulfate (0.5 mg/kg i.v.). A left lateral thoracotomy was then performed in the fifth intercostal space. A silicone rubber catheter (1.57 mm i.d., 3.18 mm o.d.) was inserted into the descending thoracic aorta for later use in withdrawing arterial reference blood samples during microsphere injection. The pericardium was then opened widely to provide access to the left ventricle. A second silicone rubber catheter was implanted into the left atrium through the appendage for microsphere injection. A stab wound was made in the left ventricular apex through which a Konigsberg P7 micromanometer (Konigsberg Instruments, Inc., Pasadena, Calif.) and a Tygon fluid-filled catheter (1.27 mm i.d., 2.29 mm o.d.) were inserted into the left ventricle. Left ventricular pressure was measured through the fluid-filled catheter using a Statham P23Db external transducer (Gould Inc., Cleveland, Ohio) at the estimated level of the left atrium to calibrate the micromanometer in situ.
The proximal left circumflex coronary artery was dissected free from surrounding tissue for a distance of approximately 2 cm. A single crystal (10 MHz) Doppler flow probe (constructed in this laboratory) was placed around the vessel. An ameroid constrictor was positioned distal to the flow probe. The constrictor was designed to produce gradual constriction of the coronary artery 10 and has been shown to stimulate the development of collateral vessels." The ameroid material (casein) was encased in a slotted stainless steel ring (5 mm wide, 8 mm diameter) and had an internal diameter of 2.3-3.0 mm; the size was matched to produce a snug, but nonconstrictive, fit at the time of implantation. A pneumatic occlusive cuff was then placed distal to the ameroid constrictor to allow quick, reversible compression of the coronary artery.
Regional myocardial function was assessed by measuring left ventricular wall thickness using sonomicrometers. Two pairs of 5-MHz ultrasonic crystals were implanted in each dog using standard techniques. 12 One crystal (2 mm diameter) was inserted obliquely through the myocardium to a position near the endocardium using a Teflon tube (1.75 mm o.d.) surrounding the stainless steel lead wires. A second, larger crystal (6 mm diameter) attached to a Dacron patch was sewn to the epicardium in a position that minimized the ultrasonic transit time between the crys-tals. This allowed for proper orientation across the ventricular wall, which is important to reduce potential shear motion artifact. 13 One pair of crystals was implanted in the posterolateral wall to measure a region in the potentially ischemic myocardium. The proper position of this crystal was verified during surgery by performing a brief occlusion of the circumflex coronary artery to confirm the prompt development of wall dysfunction. The other pair was implanted in the anterior wall of the left ventricle near the left anterior descending coronary artery to measure wall thickening in an area not rendered ischemic during circumflex coronary artery occlusion. Finally, stainless steel wires were sewn to the left atrium for subsequent electrical pacing.
The pericardium was left open, and all wires and catheters exited the thorax through intercostal spaces adjacent to the thoracotomy and then were run subcutaneously to the dog's back where they were exteriorized and anchored with sutures between the scapulae. The thoracotomy was repaired in layers, and the pneumothorax was evacuated through a chest tube inserted through the sixth intercostal space. Ampicillin (6.6 mg/kg i.m., b.i.d.) was administered throughout the surgery and for 3 days postoperatively.
Measurement of Regional Myocardial Blood Flow
Regional myocardial blood flow was measured using radionuclide-labelled microspheres (15 /xm diameter, New England Nuclear, Boston, Mass.). Three of the following radionuclide labels were used in a given dog: Ce-141, Cr-51, Sn-113, Ru-103, Nb-95, or Sc-46. The 6 labels were used randomly except for Cr-51, which was only used during resting conditions when no ischemia was anticipated. This was done because of the low concentration of spheres obtained from the manufacturer and the need to assure the delivery of sufficient numbers of spheres to tissues of interest. For each of the other 5 radionuclides, 6-10million spheres (1-2 ml injectate volume) were injected into the left atrium for each measurement. This resulted in greater than 400 spheres in all tissue samples (0.5-1.0 g wet weight). The microspheres were suspended in 10% dextran with Tween 80 by the manufacturer. Before injecting the first dose of microspheres, 2 ml dextran solution were administered through the left atrial catheter to test for sensitivity to this solution that is observed occasionally, resulting in temporary, severe hypotension. None of the dogs in this study displayed this sensitivity. Details of the measurement of blood flow in this laboratory have been published previously 1 and generally follow the methodology outlined by Heymann and associates. 14 Tissue or arterial blood samples were placed in a Packard Model 5912 Autogamma spectrometer to determine the quantity and energy level of gamma radiation. Energy windows were set to correspond to the primary energy peak of each radionuclide used in a given study. The number of counts per energy window attributable to a specific radionuclide was determined by solving simultaneous equations using a matrix in-version technique. 15 Data are presented as blood flows per wet weight of the tissue. While only 2 transmural sections are reported (corresponding to the 2 sonomicrometer locations), other samples were taken to confirm that the ischemic zone tissue was representative of the central ischemic zone (see "Histological Examination" below).
Experimental Protocol
All dogs were examined 1 week after surgery to measure regional wall thickening at a time before the ameroid constrictor produced significant stenosis. This examination included a 10-second, complete occlusion of the left circumflex coronary artery, followed by rapid, complete release to measure regional dysfunction and subsequent hyperemia. These baseline measurements were then used as guides for assessing subsequent constriction of the vessel and the development of collateral circulation. Additionally, a brief (2-minute) control run was performed by each dog to measure wall thickening during exercise without coronary constriction. The dosage of atenolol required to reduce exercise heart rate by at least 40 beats per min was determined (0.3-1.0 mg/kg i.v.). This dose also eliminated the inotropic effect (increase in left ventricular dP/dt) of 150 fig (i.v.) dobutamine hydrochloride. Dogs were then examined periodically until an indication of constriction and/or collateral development was apparent. The final assessment for determining the time of the study was always done using the amount of regional dysfunction induced by exercise. We attempted to produce an amount of regional myocardial dysfunction such that systolic wall thickening decreased greater than 50% during exercise compared to the resting control value. This was accomplished in 8 of 9 dogs; 1 dog had a reduction of only 39% during exercise but was included since no difference was observed in the response of this animal compared with the others. Dogs were studied an average of 19 ± 5 days postoperatively. On the day of study, 3 dogs had an open circumflex coronary artery. Six dogs were studied with the left circumflex coronary artery completely closed and, therefore, the posterolateral wall was collateral dependent even at rest. Subdivision of the dogs according to the patency of the left circumflex artery did not result in significant differences, so all 9 dogs were combined for analysis.
On the day of the study, control measurements were made with the dogs standing quietly on the treadmill. Despite the dogs being well trained and quiet while control measurements were made, the heart rate observed (107 ± 20 bpm) was higher than a true resting heart rate and likely reflects the dogs' anticipation for running. A microsphere injection was made while the dogs stood on the treadmill, and wall-thickness measurements, left ventricular pressure, and circumflex artery flow velocity (in the 3 dogs with an open circumflex coronary artery) were monitored continuously throughout the injection and 2-minute withdrawal of arterial blood. Dogs were then run at the speed and inclination (5-7 mph, 5-10% inclination) determined previously to produce regional myocardial dysfunction in the posterolateral wall. Once a steady state was obtained, a second, differently labelled microsphere injection was made into the left atrium. Dogs were run until the 2-minute arterial blood withdrawal was complete. The second microsphere injection was done between 3 and 4 minutes into the control run, and the total run time was between 5 and 6 minutes. Data were collected for one-half hour following the run with the dogs standing on the treadmill.
A second, identical run was performed 3 hours after the control run. A previous study (using dogs prepared as described in this study) documented that runs performed 3 hours apart without intervention were identical in terms of hemodynamics, regional myocardial perfusion, and wall function. 2 Fifteen minutes before the second run, atenolol was administered. After measurements were made while the dogs stood quietly on the treadmill, a second run was performed at the same speed and inclination as the first. After a steady state was established (1.5-2.0 minutes), the heart rate was matched to that observed during the control run by electrical stimulation of the atrium (Medtronic 5325, Medtronic, Inc., Minneapolis, Minn.). Once a new steady state was achieved (an additional 1.5-2.0 minutes), microspheres labelled with a third radionuclide were injected during arterial blood withdrawal, and total run time was the same as that during the control run. Atrial pacing was discontinued at the end of the run. Data were again collected for one-half hour following the end of the run.
To avoid prolonged running time and added technical difficulty to these already complex experiments, blood flow was not measured during the run with atenolol before the beginning of atrial pacing. We have previously reported an improvement in both regional blood flow and function in poststenotic myocardium in this experimental model following the administration of atenolol. 1 In that study, systolic wall thickening in the ischemic zone improved from 4% in the control run to 9% (p<0.01) in the atenolol run with an improvement of subendocardial blood flow per beat from 0.0020 to 0.0031 ml/g (p<0.05). We verified such a response in the present study by confirming an improvement in regional function during the atenolol run before atrial pacing, and we assume that blood flow was also increased at this time.
Histological Examination
After killing the animals at the end of the study, the hearts, with the instrumentation intact, were removed, cleaned, and fixed in 10% formalin. The atria, right ventricle, and epicardial fat were removed, and the left ventricle was sliced perpendicularly to the long axis to produce a 2-cm wide ring of myocardium containing the ischemic zone sonomicrometer. The locations of the ultrasonic crystals were carefully mapped to confirm proper orientation across the left ventricular wall. A transmural plug was then cut to include both subendocardial and epicardial transducers. This was then cut in transmural thirds, weighed, and placed in glass counting vials. The remainder of the ring was divided into additional transmural plugs that were divided into thirds, weighed, and the gamma radiation determined. Therefore, regional myocardial blood flow was measured in the entire left ventricular ring divided in transmural thirds. We report only the blood flow at the 2 sonomicrometer locations (ischemic and control zones) in 3 transmural layers, but the additional data confirmed that the ischemic zone sample was representative of the central ischemic zone and not a border zone sample. The 3 transmural tissue samples at the site of the ischemic zone sonomicrometer were later cut and stained for histological examination to determine if any myocardial necrosis was associated with the closure of the ameroid constrictor. All dogs in this study sustained necrosis of all or part of the posterior papillary muscle, but no tissue damage was detected between the ultrasonic crystals in the ventricular wall.
Data Analysis
Data were recorded on a Gould Brush Model 202 forced-ink recorder and on one-half inch magnetic tape (model 3520B, Hewlett-Packard, Inc., Waltham, Mass.). Magnetic tapes were replayed later for digitization, beat averaging, and analysis using a DEC LSI-11 computer (Digital Equipment Corp., Stow, Mass.) interfaced with an A/D converter. Parameters measured were wall thicknesses at end-diastole (defined as the time coincident with the onset of a positive left ventricular dP/dt) and end-systole (defined as the time of peak wall thickening occurring within the 20-msec interval before peak negative dP/dt), left ventricular peak and end-diastolic pressures, blood flow velocity in the left circumflex coronary artery, left ventricular dP/dt, and heart rate. Wall thickening during systole is presented as the percent change occurring from the end-diastolic dimension (%WT). The effect of exercise on %WT was further characterized by expressing %WT as a percent of the resting control value. The product of left ventricular peak systolic pressure and heart rate was calculated for use as an index of cardiac work and oxygen consumption. For all parameters, 20 consecutive beats were averaged for each observation.
Statistical analysis was done using a two-way analysis of variance for repeated measures, and when differences were detected, Tukey's least significant difference test was used to determine which means differed. 16 Data are reported with standard deviations, and ap value of 0.05 or less was accepted to indicate a significant difference between mean values.
Results
An original tracing from a run with atenolol is presented in Figure 1 . To facilitate the statistical analysis, hemodynamic and wall-thickening data were analyzed at 3 time points during each run: 1) resting control, 2) early steady-state exercise (without pacing in the atenolol run), and 3) later steady state at the time of microsphere injection (during atrial pacing in the atenolol run). Although not used in the statistical analysis, additional time points during the runs were compared to . During steady-state run, atrial pacing was begun (PACE) to increase HR to rate observed during control run done before fl-blockade. Regional myocardial blood flow was determined using radio-labelled microspheres (SPHERES) during steady state achieved with atrial pacing. Systolic wall thickening decreased with pacing, thereby reversing beneficial effect of fi-blockade on regional function in ischemic zone during confirm the existence of hemodynamic and functional steady states to validate the microsphere determination of blood flow.
Hemodynam ics
Heart rate before the control run was 107 ± 20 beats per minute, and it increased substantially to 218 ± 22 beats per minute during late control run (Table 1) . Left ventricular peak and end-diastolic pressures increased, and peak positive left ventricular dP/dt increased markedly to 4,730 ± 844 mm Hg/sec while the product of LVP and heart rate increased 2.28-fold (Table 1) .
Following administration of atenolol, heart rate at rest was 102 ± 24 beats per minute (NS from control rest), and it increased with exercise to 166 ± 15 beats per minute (p<0.01); this was significantly reduced compared with the control run. Atrial pacing then increased heart rate to 217 ± 23 beats per minute, which was identical to that observed during the control run. Peak left ventricular pressure was reduced by atenolol at rest and during exercise (Table 1) , and end-diastolic pressure was not changed by atenolol at rest or during exercise without pacing. Atrial pacing during the atenolol run caused a reduction of end-diastolic left ventricular pressure from 26.0 to 19.0 mm Hg (Table 1) . Left ventricular peak dP/dt was reduced only slightly (NS) at rest after atenolol, and it did not increase during exercise but did increase with the addition of atrial pacing. However, peak dP/dt was still significantly less than that observed during the control run. The product of LVP and heart rate increased significantly during exercise with atenolol and further increased with the addition of atrial pacing but was still less than that observed in the control run (Table 1) .
Regional Myocardial Function
Regional myocardial wall thickening during systole for both the ischemic and control zones at rest are presented in Table 2 and Figure 2 . Systolic wall thickening in the ischemic zone during resting conditions averaged 27.8 ± 9.5% with a range of 20 to 44%. In the control zone, %WT was 32.4 ± 9.7% at rest with a range of 23 to 55%.
During the control exercise, %WT in the ischemic zone decreased markedly to 7.2 ± 8.1% or 23% of the resting value at the time blood flow was measured with microspheres ( Figure 2 ). After atenolol administration, resting %WT was somewhat reduced, and exercise without atrial pacing (i.e., with heart rate reduced compared with the control run) produced less dysfunction in the ischemic zone (%WT decreased only 50% after atenolol administration) ( Figure 2 , Table 2 ). However, atrial pacing to match the heart rate to the rate observed during the control run caused a decrease in %WT to 4.1 ± 7.1%, which was only 15% of the resting value, and no longer improved compared with the control run. This effect was observed consistently in all 9 dogs studied; no single dog had a residual beneficial effect on wall function when the heart rate reduction was prevented in the atenolol run.
In the control zone, control exercise caused an in-creased %WT, which was maintained throughout the run (Figure 2 , Table 2 ). After atenolol, resting %WT was less than control rest, it did not increase during exercise, and no changes were observed with the addition of atrial pacing. At this time, both %WT and normalized %WT were significantly less than the values observed during the control run ( Table 2) .
Regional Myocardial Blood Flow
The regional myocardial blood flows determined using microspheres for the ischemic posterolateral wall and the control anterior wall are presented in Table 3 and Figure 3 . At rest, there were no differences in the blood flow to the potentially ischemic wall and control wall confirming that no perfusion defect existed under resting conditions. During the control exercise, a significant change was observed in the transmural blood flow pattern of the ischemic wall with decreased subendocardial blood flow, increased subepicardial blood flow, and a greatly reduced subendocardial blood flow per beat and the ratio between subendocardial and subepicardial blood flows (endo/ epi) ( Table 3 ). During exercise after atenolol administration, at a matched (paced) heart rate, both subendocardial blood flow and subendocardial blood flow per beat were less than values obtained during the control run, although the reduction was not significant.
In the control wall, the control exercise was associated with a transmural increase in blood flow ( Figure  3 ) and a maintenance of subendocardial blood flow per beat (Table 3 ). Following atenolol, the absolute level of blood flow was slightly less (NS) but similar to the control run in its transmural distribution.
Discussion
/3-Adrenergic blockade is commonly used to treat patients with angina pectoris. The effects of atenolol were previously studied experimentally in an animal model of single vessel chronic coronary stenosis producing ischemia and wall dysfunction during exercise, and it was shown to produce modest improvements in both subendocardial blood flow and wall function. 1 This previously reported action was confirmed by the present finding of an improvement in regional systolic wall thickening from a decrease of 73% in the control run to a decrease of only 50% early during the atenolol run, before pacing was begun. The purpose of the present study was to determine the importance of heart rate reduction to this beneficial effect of /3-blockade during exercise-induced regional myocardial ischemia. The data indicate that when the heart rate reduc-tion was prevented by atrial pacing, both regional myocardial perfusion and wall thickening did not improve after atenolol administration; instead, the data suggest a further depression of blood flow during exercise together with deterioration of regional function. Therefore, heart rate reduction appears to be the only significant mechanism acting to improve exercise-induced ischemia after /3-adrenergic blockade in this model.
It might be postulated that atrial pacing contributed to the deterioration of function in the ischemic zone by causing less effective atrial contraction. This possibility is unlikely since atrial pacing caused no change of function in the control region. Also, the deterioration of regional wall thickening in the ischemic zone occurred over a period of approximately 30 seconds, beginning with the onset of pacing. This time course to a stable dysfunction is similar to that observed with the onset of exercise, when wall thickening in the ischemic zone initially increases and then decreases over time to steady-state dysfunction. 4 Therefore, the deterioration . %WTin ischemic zone did not decrease during exercise before pacing as much as during control run, verifying beneficial effect offi-blockade when heart rate is decreased. With atrial pacing, %WT decreased significantly so that %WT tended to be less than that observed in control run at the matched heart rate. * p<0.05 vs. rest; tp<0.05 vs. run no pacing; t p< 0.05, ttp<0.01 vs. control of function in the ischemic zone was not likely an artifact of atrial pacing, which should have an immediate effect, but rather an intensification of regional ischemia.
The findings of this study emphasize the importance of an increased diastolic perfusion time (caused by decreased exercise heart rate) associated with /3-blockade for reducing ischemia and maintaining regional wall function. The dependence of subendocardial perfusion on heart rate has been demonstrated experimentally where antegrade coronary flow is limited by a stenosis and a region is collateral dependent. 6 An increase in subendocardial blood flow during exercise after /3-blockade compared with control exercise was reported by Matsuzaki et al in the model used in the present study, even though some animals had a flowlimiting stenosis while others were completely collat-eral dependent. 1 In the present study, 6 of the 9 dogs were studied after complete occlusion of the coronary artery. The improvement of subendocardial blood flow per minute in the ischemic zone during exercise after atenolol, together with decreased heart rate, results in a very substantial increase in subendocardial blood flow per beat, 1 which is an important determinant of regional myocardial function. 17 Gallagher et al 17 further demonstrated that the relation between reduced subendocardial blood flow per beat and reduced wall thickening at rest was similar to what was observed during exercise. 17 Thus, the present finding of a loss of all beneficial effect of /3-blockade when the negative chronotropic effect was prevented confirms the overwhelming importance of diastolic perfusion time for determining subendocardial blood flow per beat in an ischemic region. Additionally, these data support a close correlation between subendocardial blood flow per beat and regional myocardial wall function.
Because of the multiple effects of /3-blockade on ventricular hemodynamics and contractility during exercise, other mechanisms may also be operative in reducing ischemia and improving wall function. With the reduced heart rate and systolic pressure during exercise after /3-blockade, myocardial oxygen consumption per minute is decreased, and such an effect in nonischemic tissue adjacent to the ischemic myocardium should result in less metabolic vasodilation and potentially reverse any "steal" phenomena that may be active during regional ischemia. 78 This is particularly important for nonischemic subepicardial tissue overlyl»chemlc Area Conlrol Area
. Transmural distribution of regional myocardial blood flow in ischemic area (posterior wall, left panel) and control area (anterior wall, right panel). At rest (•), blood flow was not different in the two regions, but during control run (•), ischemic wall showed marked transmural heterogeneity since blood flow in the subendocardium (ENDO) and midmyocardium (MID) failed to increase. Control area showed a transmural increase in blood flow. During run with fi-blockade and atrial pacing (A), ENDO blood flow in ischemic region was significantly decreased compared with rest, and blood flow to control region tended to be reduced. EPI, subepicardium; TM, mean transmural blood flow; ENDOIEPI, ratio of subendocardial to subepicardial blood flow, n = 9, mean ± SD. * p<0.05, ** p<0.01 vs. rest. ing the ischemic subendocardium. Matsuzaki et al found an improved endo/epi flow ratio in the ischemic myocardium during exercise after /3-blockade with increased subendocardial blood flow and decreased subepicardial blood flow. 1 Therefore, a more favorable transmural flow distribution was achieved, resulting in enhanced regional performance by reversal of a transmural coronary "steal." In the present study, there was no improvement in the endo/epi flow ratio during exercise after atenolol with pacing, indicating that reversal of steal was not of major functional importance when heart rate is controlled. Thus, heart rate reduction appears to be efficacious in reversing transmural steal, whereas merely preventing the increase in inotropic state during exercise (/3-blockade without a simultaneous negative chronotropic effect) has no demonstrable beneficial effect on the transmural distribution of blood flow during exercise-induced regional myocardial ischemia.
Were it true that ischemia could be described by a simple oxygen supply-demand inequality and that exercise leads to "relative ischemia" by augmenting oxygen demand in a flow-limited bed, then a residual beneficial effect might be predicted during the atenolol run, even when atrial pacing reversed the negative chronotropic effect. The prevention of enhanced inotropic state during exercise together with the somewhat lower systolic left ventricular pressure caused by atenolol should have yielded less metabolic demand in the ischemic zone and less of a discrepancy between the limited supply and the demand. Since a beneficial effect (in terms of regional blood flow and function) was not evident during atrial pacing in the atenolol run, the above concept of supply-demand appears to be of little relevance in this setting. Rather, these data support the view that steady-state ischemia is best described by a reduction of absolute blood flow per beat and a propor-tional reduction of wall thickening, i.e., "absolute" rather than "relative" ischemia. 4 This view is supported by the previous finding that increased subendocardial perfusion was associated with increased wall motion after atenolol administration in this model when exercise heart rate was significantly reduced. 1 These studies were not designed to compare the overall circulatory effects of the interventions used but rather to examine the cardiac effect of atenolol plus pacing compared with a control run at a matched external exercise workload. Cardiac workload, reflected by the heart rate-systolic left ventricular pressure product (Table 1) , was markedly lowered during running after atenolol and remained lower than control even during pacing. This reflected the lowered systolic pressure consequent to atenolol, but this potentially beneficial reduction of myocardial oxygen consumption was not sufficient to offset the unfavorable effect of restoring heart rate on myocardial perfusion and oxygen supply.
The increase in heart rate by atrial pacing during the atenolol run was accompanied by a slight decrease in left ventricular end-diastolic pressure compared with the control run. Thus, both end-diastolic and peak systolic ventricular pressures were lower in the atenolol run at a matched heart rate. Decreased systolic pressure (as a reflection of afterload) would tend to improve wall function while reduced end-diastolic pressure might limit the utilization of preload reserve, thereby reducing wall performance. However, enddiastolic wall thickness in the control zone increased with pacing during the atenolol run, while in the ischemic zone it did not, indicating differential effects in the two zones. In addition, any effect of lower diastolic pressure to improve subendocardial perfusion was not evident since the reduced systolic wall thickening in the ischemic zone suggests an intensification of ischemia in the poststenotic myocardium.
Several mechanisms could have contributed to the worsening of wall dysfunction when heart rate was artificially paced to the rate observed during the control run. One possibility is that /3-blockade prevents the normal increase in contractility of nonischemic subepicardial layers overlying the ischemic tissue exercise. The contractile function of this subepicardium might contribute significantly to overall wall function during subendocardial ischemia." Our data suggest, however, that regional blood flow as well as function was depressed more after atenolol than during the control run at matched heart rates. Thus, an intensification of the ischemia per se may have caused the worsening of wall dysfunction. This could be due to unmasking of a vasoconstrictor effect during exercise after /3-blockade; a-adrenergic vasoconstriction has been demonstrated distal to a coronary stenosis, 18 and sympathetic nerve stimulation has been shown to intensify ischemia distal to a coronary stenosis by activation of a 2 -adrenoceptors. 19 More recently, Seitelberger and coworkers in this laboratory have studied a model of acute coronary stenosis in exercising dogs after /3-blockade, in which selective intracoronary a 2 -adrenergic receptor blockade produced a significant increase in regional wall thickening. 20 Therefore, it is reasonable to postulate that /3-adrenergic blockade in the present study unmasked a 2 -adrenergic vasoconstriction in the ischemic myocardium, which resulted in the deterioration of regional blood flow and function. Additional studies would be required to substantiate this hypothesis, but if correct it would suggest that a 2 -adrenergic blockade, or a calcium antagonist that functionally blocks a 2adrenergic vasoconstriction 2122 in combination with a /3-blocking agent, might prevent unmasking of vasoconstrictor effects in ischemic myocardium. 23 -24 Our results emphasize the great importance of diastolic perfusion time on blood flow during exercise to a collateral-dependent subendocardial region. Additionally, the finding that regional blood flow and function were further depressed during exercise with atenolol when the bradycardic effect of atenolol was prevented suggests an unmasking by /3-blockade of a vasoconstrictor effect. Our results suggest that the use of specific bradycardic agents 23 might be useful in the treatment of exercise-induced ischemia, since their use would avoid the negative inotropic action of /3-adrenergic blocking drugs.
